Combination microRNA-based cellular reprogramming with paclitaxel enhances therapeutic efficacy in a relapsed and multidrug-resistant model of epithelial ovarian cancer-Reference-Cited by-同舟云学术

Combination microRNA-based cellular reprogramming with paclitaxel enhances therapeutic efficacy in a relapsed and multidrug-resistant model of epithelial ovarian cancer

Published:2022-06 Issue: Volume:25 Page:57-68
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Gandham Srujan K.,Rao Mounika,Shah Aayushi,Trivedi Malav S.,Amiji Mansoor M.^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference46 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J. Clin.,2021

2. SEER Cancer Statistics Review, 1975-2014;Howlader,2017

3. Whole-genome characterization of chemoresistant ovarian cancer;Patch;Nature,2015

4. Revisiting the role of ABC transporters in multidrug-resistant cancer;Robey;Nat. Rev. Cancer,2018

5. Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research;Ahmed;Front Oncol.,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research;Molecular Cancer;2024-08-14

2. MicroRNA‑mediated approaches in ovarian cancer therapy: A comprehensive systematic review;Oncology Letters;2024-08-12

3. MiR-223-3p in Cancer Development and Cancer Drug Resistance: Same Coin, Different Faces;International Journal of Molecular Sciences;2024-07-26

4. Transcriptome profiling and characterization of peritoneal metastasis ovarian cancer xenografts in humanized mice;Scientific Reports;2024-05-24

5. Current strategies for early epithelial ovarian cancer detection using miRNA as a potential tool;Frontiers in Molecular Biosciences;2024-04-16